2m 2m 2m 2m 2m 2m 2m
Evogene (EVGN)
NASDAQ
$0.56-$0.03 (-4.42%)
Price as of Jun 03, 2026 7:07 PM EDT- $25.1MMarket Cap
- -46.84%1-Year Change
- BiotechnologyIndustry
Evogene (EVGN)
$0.56-$0.03 (-4.42%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.9M -54.73% | 8.5M +50.90% | 5.6M +236.72% | 1.7M +80.11% | |
Cost of Revenue | 4.1M +52.59% | 2.7M +58.57% | 1.7M +86.14% | 909,000 +18.51% | |
Gross Profit | -241,000 -104.14% | 5.8M +47.62% | 3.9M +415.40% | 766,000 +369.94% | |
Sales and Marketing Expense | 4.3M -42.40% | 7.4M +22.63% | 6.1M -6.39% | 6.5M -10.63% | |
Research and Development Expense | -8.0M -51.98% | -16.6M -19.87% | -20.8M -0.07% | -20.8M -1.58% | |
Depreciation and Amortization Expense | 1.1M -25.23% | 1.5M -6.76% | 1.6M +8.46% | 1.5M +16.21% | |
Total Operating Expenses | 4.3M -42.40% | 7.4M +22.63% | 6.1M -6.39% | 6.5M -10.63% | |
Operating Profit | -14.0M -36.81% | -22.2M -16.21% | -26.5M -1.61% | -26.9M -12.96% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 37,000 +107.06% | -524,000 N/A | 0 -100.00% | 3.5M N/A | |
Income before Taxes | -7.8M -56.65% | -18.1M -30.44% | -26.0M -13.03% | -29.8M -1.97% | |
Income Taxes | 1,000 -88.89% | 9,000 +127.27% | -33,000 -136.67% | 90,000 +592.31% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -7.8M -56.65% | -18.1M -30.44% | -26.0M -13.03% | -29.8M -1.97% | |
Net Income from Continuing Operations Applicable to Common | -7.8M -56.65% | -18.1M -30.44% | -26.0M -13.03% | -29.8M -1.97% | |
Basic EPS and Net Income | 1.08 +137.37% | -2.89 +455.77% | -0.52 -20.00% | -0.65 N/A | |
Diluted EPS and Net Income | 1.08 +137.37% | -2.89 +455.77% | -0.52 -20.00% | -0.65 N/A | |
Basic Weighted Average Shares | 7.9M +38.21% | 5.7M -87.53% | 45.7M +10.86% | 41.2M +1.92% | |
Diluted Weighted Average Shares | 7.9M +38.21% | 5.7M -87.53% | 45.7M +10.86% | 41.2M +1.92% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 13.0M -15.33% | 15.3M -26.34% | 20.8M -28.32% | 29.0M -10.35% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 13.0M -15.33% | 15.3M -26.34% | 20.8M -28.32% | 29.0M -10.35% | |
Total Current Assets | 15.6M -27.60% | 21.6M -37.37% | 34.5M -8.69% | 37.8M -33.64% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 812,000 -54.99% | 1.8M -26.52% | 2.5M -1.76% | 2.5M +20.55% | |
Total Long-Term Assets | 4.4M -75.84% | 18.3M +9.88% | 16.6M -9.49% | 18.4M -5.35% | |
Total Assets | 20.0M -49.71% | 39.9M -21.99% | 51.1M -8.95% | 56.1M -26.44% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 3.4M -81.58% | 18.7M +169.23% | 6.9M +23.45% | 5.6M -18.27% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 4.6M -26.92% | 6.3M -59.08% | 15.5M -1.52% | 15.7M +161.76% | |
Total Liabilities | 8.1M -67.75% | 25.0M N/A | N/A N/A | N/A N/A | |
Retained Earnings | -282.6M +3.10% | -274.1M +6.40% | -257.6M +10.22% | -233.7M +12.86% | |
Total Stockholders Equity | 12.0M -19.30% | 14.8M -48.27% | 28.7M -17.55% | 34.8M -45.14% | |
Total Shares Outstanding | 8.7M +33.83% | 6.5M -87.12% | 50.6M +22.60% | 41.3M +0.22% | |
Cash Flow | |||||
Cash from Operating Activities | -13.5M -31.46% | -19.7M -8.70% | -21.6M -8.87% | -23.7M -4.20% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 17.7M +84.35% | 9.6M +312.03% | -4.5M -134.19% | 13.3M +164.54% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -6.6M -241.80% | 4.7M -74.35% | 18.2M +94.28% | 9.3M -69.14% | |
Financials Ratio | |||||
Gross Margin | -6.25% -109.13% | 68.48% -2.18% | 70.00% +53.07% | 45.73% +160.92% | |
Operating Margin | -364.24% +39.58% | -260.96% -44.48% | -470.00% -70.78% | -1,608.42% -51.67% | |
Return on Assets | -26.13% -34.17% | -39.69% -18.00% | -48.41% +7.41% | -45.07% +9.71% | |
Return on Equity | -58.38% -29.63% | -82.96% +1.45% | -81.78% +34.56% | -60.78% +20.08% | |
Revenue Growth | -54.73% -207.51% | 50.90% -78.50% | 236.72% +195.50% | 80.11% +857.38% | |
Current Ratio | 4.54 +293.02% | 1.15 -76.74% | 4.96 -26.04% | 6.71 -18.81% | |
Cash Ratio | 3.76 +359.61% | 0.82 -72.64% | 2.99 -41.94% | 5.15 +9.69% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow